Anti-MTFR1L monoclonal antibody

Pre-made anti-MTFR1L monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MTFR1L/MTFR1L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2610-Ab-1/ GM-Tg-hg-IP2610-Ab-2Anti-Human MTFR1L monoclonal antibodyHuman
GM-Tg-rg-IP2610-Ab-1/ GM-Tg-rg-IP2610-Ab-2Anti-Rat MTFR1L monoclonal antibodyRat
GM-Tg-mg-IP2610-Ab-1/ GM-Tg-mg-IP2610-Ab-2Anti-Mouse MTFR1L monoclonal antibodyMouse
GM-Tg-cynog-IP2610-Ab-1/ GM-Tg-cynog-IP2610-Ab-2Anti-Cynomolgus/ Rhesus macaque MTFR1L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2610-Ab-1/ GM-Tg-felg-IP2610-Ab-2Anti-Feline MTFR1L monoclonal antibodyFeline
GM-Tg-cang-IP2610-Ab-1/ GM-Tg-cang-IP2610-Ab-2Anti-Canine MTFR1L monoclonal antibodyCanine
GM-Tg-bovg-IP2610-Ab-1/ GM-Tg-bovg-IP2610-Ab-2Anti-Bovine MTFR1L monoclonal antibodyBovine
GM-Tg-equg-IP2610-Ab-1/ GM-Tg-equg-IP2610-Ab-2Anti-Equine MTFR1L monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2610-Ab-1/ GM-Tg-hg-IP2610-Ab-2; GM-Tg-rg-IP2610-Ab-1/ GM-Tg-rg-IP2610-Ab-2;
GM-Tg-mg-IP2610-Ab-1/ GM-Tg-mg-IP2610-Ab-2; GM-Tg-cynog-IP2610-Ab-1/ GM-Tg-cynog-IP2610-Ab-2;
GM-Tg-felg-IP2610-Ab-1/ GM-Tg-felg-IP2610-Ab-2; GM-Tg-cang-IP2610-Ab-1/ GM-Tg-cang-IP2610-Ab-2;
GM-Tg-bovg-IP2610-Ab-1/ GM-Tg-bovg-IP2610-Ab-2; GM-Tg-equg-IP2610-Ab-1/ GM-Tg-equg-IP2610-Ab-2
Products NameAnti-MTFR1L monoclonal antibody
Formatmab
Target NameMTFR1L
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MTFR1L monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2610-Ag-1Recombinant multi-species MFR1L/ MTFR1L/ FAM54B protein


    Target information

    Target IDGM-IP2610
    Target NameMTFR1L
    Gene ID56181,76824,298549,713213,487365,101081482,508852,100071263
    Gene Symbol and Synonyms2410166I05Rik,FAM54B,HYST1888,MST116,MSTP116,MTFR1L,RGD1305453
    Uniprot AccessionQ9H019,Q5XII9,Q3ZBW7
    Uniprot Entry NameMFR1L_HUMAN,MFR1L_RAT,MFR1L_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000117640
    Target ClassificationN/A

    The target: MTFR1L, gene name: MTFR1L, also named as FAM54B, HYST1888, MST116, MSTP116. Predicted to be involved in aerobic respiration and mitochondrial fission. Predicted to be active in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.